Monsea Ltd. Report issue

For profit Phase 3
Founded: Czech Republic (2005)
Status: Defunct (2010)

Organization Overview

First Clinical Trial
2011
NCT01410955
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2011

Timeline

NOW
  • Now